Ignite Creation Date:
2025-12-24 @ 11:06 PM
Ignite Modification Date:
2025-12-31 @ 12:29 PM
Study NCT ID:
NCT05033769
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2020-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer
Sponsor:
Institut fuer Frauengesundheit
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-09-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-19
First Submit QC Date:
None
Study First Post Date:
2021-09-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-04-14
Last Update Post Date:
2023-04-18
Last Update Post Date Type:
ACTUAL